Clinical trials: Erectile Dysfunction
Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction
Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered
The purpose of this study is to evaluate pharmacokinetics, safety and tolerability profile of BZ371A topically administered in healthy patients.
- Conditions
- Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction, Prostate Cancer, Radical Prostatectomy
- Trial name
- NCT05332340
- Testing
- BZ371A
- Where
- Brazil
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Biozeus Biopharmaceutical S.A.
Erectile Dysfunction
Low Intensity Shock Wave Therapy in the Rehabilitation Treatment of Erectile Dysfunction After Robotic Radical Prostatectomy.
The study deals with the hypothesis that LiESWT in addition to the administration of PDE5i can improve sexuality rehabilitation with faster recovery of a valid erection and higher IIEF-5 scores in the short and medium-term…
- Trial name
- NCT06442020
- Testing
- Tadalafil (PDE5i)
- Where
- Italy
- Volunteers
- 158 people
- Sponsor
- Regina Elena Cancer Institute
Erectile Dysfunction
Satisfaction, Confidence and Naturalness in Men With Psychogenic Erectile Dysfunction (ED)
Context and Objectives: Erectile dysfunction severely compromises not only sexual satisfaction, which is well known to be closely linked to overall life satisfaction but is also associated with a lower quality of life, lower…
- Trial name
- NCT01153204
- Testing
- Group Psychotherapy, Group Psychotherapy plus Sildenafil citrate, Sildenafil citrate
- Volunteers
- 30 people
- Sponsor
- Federal University of São Paulo
Impotence
Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection
To determine if men with problems getting and keeping an erection prefer treatment with tadalafil or sildenafil.
- Trial name
- NCT00547352
- Testing
- tadalafil, sildenafil
- Where
- South Korea
- Volunteers
- 160 people
- Sponsor
- Eli Lilly and Company
Erectile Dysfunction
Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men
The primary aim of this open, uncontrolled, prospective, non-interventional post-marketing surveillance study is to obtain data on safety and efficacy of Levitra in routine treatment of erectile dysfunction.
- Trial name
- NCT00470873
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Where
- Poland
- Volunteers
- 2,471 people
- Sponsor
- Bayer
Erectile Dysfunction
A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients
A Multicenter, Randomized, Double-blind, Phase Ⅲ Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients
- Trial name
- NCT07899073
- Testing
- HIP2602 + HPP2602-2, HPP2602-1 + HPP2602-2, HGP1201 + HPP2602-1
- Where
- South Korea
- Volunteers
- 225 people
- Sponsor
- Hanmi Pharmaceutical Company Limited
Erectile Dysfunction
Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction
This will be an open-label, non-randomized, multi-center, patient sponsored study of Adipose-Derived Stromal Vascular Fraction cells (AD-SVF) implantation delivered into the corpus cavernous in patients with Erectile Dysfunction.
- Trial name
- NCT02087397
- Testing
- Liposuction, AD-SVF Cell Injection
- Where
- United States
- Sponsor
- Ageless Regenerative Institute
Erectile Dysfunction
Shock Wave vs. On-demand Tadalafil for Erectile Dysfunction
The objective of this study is to evaluate the effectiveness and safety of focused Li-ESWT on 25 participants complaining of ED compared to 25 participants complaining of ED on medical treatment on a prospective clinical trial…
- Trial name
- NCT05199727
- Testing
- LI-ESWT, Tadalafil 20Mg Oral Tablet
- Where
- Egypt
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Menoufia University
Impotence
Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction
The study objective is to: 1. To evaluate the effect of sildenafil citrate versus placebo on the IIEF_EF Domain at the end of the double-blind phase 2.
- Trial name
- NCT00245258
- Testing
- Sildenafil Citrate
- Where
- 19 sites in Russia, South Korea and 2 more
- Volunteers
- 312 people
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Erectile Dysfunction
Efficiency and Safety of High-frequency Radio Wave Electrotherapy With a Radio Frequency of 448 kHz in the Treatment of Patients With Organic Erectile Dysfunction.
Efficiency and safety of high-frequency radio wave electrotherapy with a radio frequency of 448 kHz in the treatment of patients with organic erectile dysfunction.
- Trial name
- NCT04506658
- Testing
- high-frequency radio wave electrotherapy with a frequency of 448 kHz on the penis structures.
- Where
- Russia
- Volunteers
- 60 people
- Sponsor
- I.M. Sechenov First Moscow State Medical University
Hypertension, Erectile Dysfunction
Does Erectile Dysfonction Allow to Evaluate Subendocardial Viability Among Treated Patients With Hypertension ?
Erectile dysfunction (ED) is associated with subclinical atherosclerosis and may precede clinically apparent coronary artery disease by two to five years.
- Trial name
- DEVISE (NCT07719790)
- Where
- France
- Volunteers
- 120 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Type 2 Diabetic Patients, Erectile Dysfunction
Prevalence and Risk Factors of Erectile Dysfunction in Type 2 Diabetic Patients
The investigators evaluated 250 male, type 2 diabetic patients, aged 18-80 years. They will undergo IIEF (International Index of Erectile Function), SAS of Zung (self-rating anxiety state)and SDS of Zung (self-rating depression…
- Trial name
- NCT01049750
- Testing
- type 2 diabetic patients
- Where
- Italy
- Volunteers
- 220 people
- Sponsor
- University of Pavia
Erectile Dysfunction, Peripheral Arterial Disease
Predicting Peripheral Arterial Disease in Men With Erectile Dysfunction
Erectile dysfunction is a common complaint and is found frequently in men with hyperlipidemia, hypertension, diabetes and those who smoke. ED may also be an early warning of peripheral arterial disease.
- Trial name
- PREPARED (NCT00743613)
- Testing
- Sexual Health Inventory for Men (SHIM), Ankle-Brachial Index (ABI)
- Where
- 5 sites in United States
- Volunteers
- 175 people, healthy volunteers welcome
- Sponsor
- Bruton Avenue Family Practice
Impotence, Erectile Dysfunction
Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction
Study is a clinical study assessing the effect of oral tadalafil 10mg or 20 mg on psychosocial aspects and quality of life of erectile dysfunction patients and to compare tadalafil with previous oral erectile dysfunction…
- Trial name
- NCT00422578
- Testing
- tadalafil
- Where
- Finland
- Volunteers
- 200 people
- Sponsor
- Eli Lilly and Company
Erectile Dysfunction
LEVITRA® 20mg Special Drug Use Investigation (Long-term)
This investigation targets either the patients of 18 years-old or older and under 65 years-old with organic or mixed erectile dysfunction (ED) who cannot obtain sufficient efficacy by dose 10mg of Levitra, and the target patients…
- Trial name
- NCT00909233
- Testing
- Vardenafil, (Levitra, BAY38-9456)
- Where
- Japan
- Volunteers
- 1,221 people
- Sponsor
- Bayer
Erectile Dysfunction
Will Erectile Dysfunction Increase the Risk of Prostate Cancer
The rationale for investigating the hypothesis that there is an association between erectile dysfunction (ED) and the subsequent development of prostate cancer is based on three assumptions: 1) baseline ED is common in most if…
- Trial name
- EDtoPC (NCT03009123)
- Testing
- Erectile dysfunction
- Where
- Taiwan
- Volunteers
- 21,558 people
- Sponsor
- Kuang Tien General Hospital
Impotence, Arteriogenic
Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction
In this prospective, unblinded, single-arm, single-center study, investigators would like to assess the feasibility and safety of the bioabsorbable everolimus-eluting stents in patients with erectile dysfunction and concomitant…
- Trial name
- NCT02492386
- Testing
- Bioabsorbable everolimus-eluting stent deployment
- Volunteers
- 15 people
- Sponsor
- National Taiwan University Hospital
Erectile Dysfunction
Treatment of Erectile Dysfunction - Long Term Safety and Efficacy
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of udenafil, an orally administered selective inhibitor of PDE-5 for the treatment of subjects with erectile dysfunction (ED).
- Trial name
- NCT01065012
- Testing
- Udenafil 50 mg, Udenafil 100 mg, Udenafil 150 mg
- Where
- 72 sites in United States
- Volunteers
- 1,027 people
- Sponsor
- Warner Chilcott
Erectile Dysfunction
Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction
VL#FIA3-30 is a preparation intended for topical use, applied on the penis, for the treatment of ED.
- Trial name
- NCT02496845
- Testing
- VL#FIA3-30
- Where
- Israel
- Volunteers
- 32 people
- Sponsor
- VasoLead (2012) Ltd.
Erectile Dysfunction
A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects
This study to will compare the blood levels of sildenafil following administration of an experimental tablet vs. the conventional oral tablet.
- Trial name
- NCT00866463
- Testing
- Sildenafil
- Where
- United States
- Volunteers
- 18 people, healthy volunteers welcome
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.